Mutant EGFR and KRAS both indirectly regulate cancer metabolism by activating downstream signaling pathways for metabolic regulation including Akt, MYC, and mTORC1 [66,67], which in turn regulate practically every metabolic pathway in the cell. The gene discussed is MYC; the disease is cancer.